ATARA BIOTHERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $339.2M | $60.7M |
| FY2019 | — | $290.8M | $74.3M |
| FY2020 | — | $462.3M | $200.4M |
| FY2021 | — | $279.6M | $106.1M |
| FY2022 | — | $126.6M | $92.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $339.2M | $60.7M |
| FY2019 | — | $290.8M | $74.3M |
| FY2020 | — | $462.3M | $200.4M |
| FY2021 | — | $279.6M | $106.1M |
| FY2022 | — | $126.6M | $92.9M |